[HTML][HTML] Preserving fertility in female patients with hematological malignancies: a multidisciplinary oncofertility approach
Oncofertility is a new interdisciplinary field at the intersection of oncology and reproductive
medicine that expands fertility options for young cancer patients. The most common forms of …
medicine that expands fertility options for young cancer patients. The most common forms of …
GnRH analogues as a co-treatment to therapy in women of reproductive age with cancer and fertility preservation
G Valsamakis, K Valtetsiotis, E Charmandari… - International journal of …, 2022 - mdpi.com
In this review, we analyzed existing literature regarding the use of Gonadotropin-releasing
Hormone (GnRH) analogues (agonists, antagonists) as a co-treatment to chemotherapy and …
Hormone (GnRH) analogues (agonists, antagonists) as a co-treatment to chemotherapy and …
Male and female fertility: prevention and monitoring Hodgkin'lymphoma and diffuse large B-cell lymphoma adult survivors. A systematic review by the Fondazione …
S Viviani, V Caccavari, C Gerardi, S Ramadan… - Cancers, 2021 - mdpi.com
Simple Summary Patients with Hodgkin lymphoma or diffuse large B-cell lymphoma treated
with chemotherapy, with or without radiation therapy on pelvic nodes, may suffer permanent …
with chemotherapy, with or without radiation therapy on pelvic nodes, may suffer permanent …
Fertility preservation in female pediatric patients with cancer: a clinical and regulatory issue
S Brancati, L Gozzo, L Longo, DC Vitale… - Frontiers in …, 2021 - frontiersin.org
Fertility preservation represents one important goal of cancer patients' management due to
the high impact on health and quality of life of survivors. The available preventive measures …
the high impact on health and quality of life of survivors. The available preventive measures …
Fertility preservation in Hodgkin's lymphoma patients that undergo targeted molecular therapies: an important step forward from the chemotherapy era
A Traila, D Dima, P Achimas-Cadariu… - Cancer management …, 2018 - Taylor & Francis
In total, 80%–90% of Hodgkin's lymphoma (HL) patients are curable with combination
chemoradiotherapy. Due to improvements in therapeutic strategies, 50% of all …
chemoradiotherapy. Due to improvements in therapeutic strategies, 50% of all …
Contemporarily treated patients with Hodgkin lymphoma have childbearing potential in line with matched comparators
CE Weibull, ALV Johansson, S Eloranta… - Journal of Clinical …, 2018 - ascopubs.org
Purpose With excellent cure rates for young patients with Hodgkin lymphoma (HL), there is
an increasing number of female survivors of HL interested in becoming pregnant. Here, we …
an increasing number of female survivors of HL interested in becoming pregnant. Here, we …
Ovarian function and fertility preservation in breast cancer: should gonadotropin-releasing hormone agonist be administered to all premenopausal patients receiving …
Chemotherapy-induced premature ovarian insufficiency (POI) is one of the potential
drawbacks of chemotherapy use of particular concern for newly diagnosed premenopausal …
drawbacks of chemotherapy use of particular concern for newly diagnosed premenopausal …
Gonadotropin-releasing hormone analogs for gonadal protection during gonadotoxic chemotherapy: a systematic review and meta-analysis
N Sofiyeva, T Siepmann, K Barlinn… - Reproductive …, 2019 - journals.sagepub.com
Objective: A systematic review and meta-analysis was conducted to investigate whether
gonadotropin-releasing hormone analogs (GnRHa) have a protective role in women treated …
gonadotropin-releasing hormone analogs (GnRHa) have a protective role in women treated …
Daganatos nőbetegek termékenységének megőrzése.
D Vesztergom, L Nánássy, C Polgár, A Krádi… - Orvosi …, 2023 - akjournals.com
A daganatos megbetegedések incidenciája az életkorral nő. Azáltal, hogy a családalapítás
ideje egyre jobban kitolódik, folyamatosan nő azon daganatos betegek száma, akiknél az …
ideje egyre jobban kitolódik, folyamatosan nő azon daganatos betegek száma, akiknél az …
Fertility preservation in lymphoma patients treated with immunochemotherapy regimens with or without radiotherapy: results of a retrospective multicenter Italian study …
O Annibali, A Castellino, N Cenfra… - Leukemia & …, 2024 - Taylor & Francis
This is a retrospective, multicentric study, aimed to describe the real-life application of fertility
preservation methods during treatment in female lymphoma patients, aged 18–40 years old …
preservation methods during treatment in female lymphoma patients, aged 18–40 years old …